|
|
 |
|
Viewing report
|
|
|
|
2010 Guide to the Life Sciences Industry for Technology Providers
Datamonitor, March 2010, Pages: 26
As drug sales drop and pressures to fill the product pipelines rise, executives are becoming more open-minded about the use of IT solutions. However, without the proper industry background, it can be difficult for technology vendors to enter this conservative market. This brief provides an overview of the life sciences industry in order for vendors to understand how to enter this market.
Scope
- Offers an overview of the pharmaceutical and biotechnology sectors
- Discusses key areas where there is greatest need for technology in the life sciences industry
- Provides go-to-market strategies to help enter the pharma and biotech markets and be successful
Highlights of this title
The life sciences industry has been experiencing slower growth in recent years, a trend that will continue if changes are not made to the cherished blockbuster model. A fundamental step in transitioning from this model is to adopt technologies that will aid in streamlining processes throughout the drug lifecycle and increasing R&D productivity.
As pressures grow to fill their dwindling product pipelines with innovative drugs, pharma companies are embracing biotechnology, biomedical research and the concept of personalized medicine. This has led to a greater demand for innovative developments from the IT sector to provide the biotech industry with the tools it requires.
The industry is known to be conservative and skeptical of commercial technologies. Historically companies built their own solutions, resulting in legacy systems that are difficult to maintain and integrate with new systems. Executives are beginning to understand the benefits of pharma-specific solutions, but need time, education and convincing.
Key reasons to purchase this title
- Understand the pharmaceutical and biotechnology product lifecycle and business processes
- Identify emerging areas of concern for pharmaceutical and biotechnology companies
- Gain insight into what solutions and services will appeal most to life sciences companies
Customers who bought this item also bought
Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Biotechnology in India - An Indian Market Report
Clinical Operations: Benchmarking Per-Patient Trial Costs, Staffing and Adaptive Design
Success with Biobetters: Young Biobetters Companies and Pipelines
Biomarkers and Tests for Pharma/ Biotech R&D – Companies Products and WW Market, 2006-2011
Tapping Biosimilar Opportunities
A Quick Guide to Clinical Trials for People Who May Not Know It All
Biosimilar Opportunities: Pipelines and Companies
Pharma Antes Up: Investment and Business Trends Driving Biotechnology
Drug Delivery Partnering Terms and Agreements in Pharma and Biotech 2nd Edition
|
|
|
|
